ASX Top 10 Momentum Stocks: 19 Sept 2023 - Finer Market Points

Sep 19, 2023

4DS RDN LDX SXG BRX SPR ALA ASX:HLA IPX CU6

Momentum leading shares are the market's best performers today. They are the fastest-growing shares on the ASX over the last 90 days. These companies can't get to be leaders without first appearing on our Launch Pad list.

The Launch Pad List is published weekly through our Friday video on our YT channel.

Today's ASX's Top 10 Quarterly Momentum Stocks are:

4Ds Memory Limited (4DS): 4Ds Memory Limited specializes in developing Interface Switching ReRAM (resistive random-access memory) technology, targeting the semiconductor industry.

Raiden Resources Limited (RDN): Raiden Resources Ltd is a resource exploration and development company, with a focus on precious and base metals in Europe. They are Ni Cu PGE miners in the WA Pilbara region and also involved in Copper-gold exploration in Serbia and Bulgaria.

Lumos Diagnostics Holdings Limited (LDX): Lumos Diagnostics engages in the development and manufacture of point-of-care (POC) diagnostics solutions to help healthcare professionals more accurately diagnose and manage medical conditions.

Southern Cross Gold Ltd (SXG): Southern Cross Gold Ltd is a gold miner in VIC goldfields of Sunday Creed, Redcastle, Whroo, plus Mt Isa in QLD.

Belararox Limited (BRX): Belararox Limited is a clean-energy-focused miner exploring for Cu, Zn, Au, Ag, Ni, Pb in NSW, WA, and Argentina.

Spartan Resources Limited (SPR): Spartan Resources Limited, formerly known as Gascoyne Resources, is focusing on the Never Never discovery, located less than 1km from the processing plant in WA.

Arovella Therapeutics Limited (ALA): Arovella Therapeutics Limited is involved in the development of therapeutics for the treatment of fibrosis and other chronic diseases.

Healthia Limited (HLA): Healthia Limited is a healthcare company that operates podiatry, physiotherapy, and other allied health clinics.

Iperionx Limited (IPX): Iperionx Limited is a biopharmaceutical company specializing in developing treatments for mitochondrial diseases and other rare diseases.

Clarity Pharmaceuticals Ltd (CU6): Clarity Pharmaceuticals Ltd is a radiopharmaceutical company engaged in the development of targeted therapies for cancer and other diseases.